Literature DB >> 3566254

In vitro susceptibility of Capnocytophaga species to antimicrobial agents.

P M Hawkey, S D Smith, J Haynes, H Malnick, S W Forlenza.   

Abstract

A total of 33 clinical isolates of Capnocytophaga spp. were susceptible to 4-quinolone antimicrobial agents. The antipseudomonal penicillins tested were equally active against all isolates, as were cefuroxime, ceftriaxone, ceftizoxime, cefotaxime, latamoxef, and ceftazidime. Most isolates were resistant to trimethoprim, and some were resistant to aztreonam. Most regimens for the empirical treatment of septic episodes in immunocompromised patients are suitable for the treatment of Capnocytophaga spp. infections.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3566254      PMCID： PMC174718          DOI： 10.1128/AAC.31.2.331

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts.

Authors:  D M Parenti; D R Snydman
Journal:  J Infect Dis       Date:  1985-01       Impact factor: 5.226

2.  Capnocytophaga sepsis: a newly recognised clinical entity in granulocytopenic patients.

Authors:  S W Forlenza; M G Newman; A I Lipsey; S E Siegel; U Blachman
Journal:  Lancet       Date:  1980-03-15       Impact factor: 79.321

3.  Capnocytophaga ochracea: an unusual opportunistic pathogen.

Authors:  G Mycock; B S Azadian
Journal:  J Clin Pathol       Date:  1985-09       Impact factor: 3.411

4.  In vitro susceptibility of Capnocytophaga strains to 18 antimicrobial agents.

Authors:  V L Sutter; D Pyeatt; Y Y Kwok
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

5.  Antimicrobial susceptibility of Capnocytophaga.

Authors:  S W Forlenza; M G Newman; A L Horikoshi; U Blachman
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

6.  Antibacterial activity of ofloxacin and other 4-quinolone derivatives: in-vitro and in-vivo comparison.

Authors:  J F Chantot; A Bryskier
Journal:  J Antimicrob Chemother       Date:  1985-10       Impact factor: 5.790

7.  In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.

Authors:  R Wise; J M Andrews; L J Edwards
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

8.  Capnocytophaga ochracea infection: two cases and a review of the published work.

Authors:  P M Hawkey; H Malnick; S A Glover; N Cook; J A Watts
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

9.  Capnocytophaga: new genus of gram-negative gliding bacteria. III. Physiological characterization.

Authors:  S S Socransky; S C Holt; E R Leadbetter; A C Tanner; E Savitt; B F Hammond
Journal:  Arch Microbiol       Date:  1979-07       Impact factor: 2.552
  9 in total
  7 in total

1.  Antimicrobial susceptibilities and beta-lactamase characterization of Capnocytophaga species.

Authors:  D L Roscoe; S J Zemcov; D Thornber; R Wise; A M Clarke
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

2.  Novel beta-lactamase from Capnocytophaga sp.

Authors:  J E Foweraker; P M Hawkey; J Heritage; H W Van Landuyt
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

Review 3.  Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.

Authors:  R N Brogden; A Ward
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

4.  In vitro susceptibilities of Capnocytophaga isolates to beta-lactam antibiotics and beta-lactamase inhibitors.

Authors:  A Jolivet-Gougeon; A Buffet; C Dupuy; J L Sixou; M Bonnaure-Mallet; S David; M Cormier
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

5.  In vitro susceptibility of 96 Capnocytophaga strains, including a beta-lactamase producer, to new beta-lactam antibiotics and six quinolones.

Authors:  G Arlet; M J Sanson-Le Pors; I M Casin; M Ortenberg; Y Perol
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

6.  Capnocytophaga infection involving a portal-systemic vascular shunt.

Authors:  K A Mello; D R Snydman; S Arora
Journal:  Dig Dis Sci       Date:  1990-07       Impact factor: 3.199

Review 7.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.